Crene Biotechnology,API,pharmaceutical intermediates,small molecules,prostaglandins,chemicals

Welcome to Crene Biotechnology!

+86-576-88205808

Cart(0)

+ AII PRODUCTS

- Prostaglandins - Custom Synthesis - PARP Inhibitors - PI3K Inhibitors - FAK Inhibitors - AKT Inhibitors - C-Kit Inhibitors - VEGFR Inhibitors - c-Met Inhibitors - CDK Inhibitors - CYP17 Inhibitors - DNA/RNA Inhibitors - mTOR Inhibitors - SRC Inhibitors - Others - Veterinary APIs - Gs-441524 - Vitamin D Analogs - Antibiotics

Catalog No	CAS NO	Product name
CR1335	1009298-59-2	AZD2014 Vistusertib Vistusertib, also known as AZD2014, is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential..
CR1334	540737-29-9	Tofacitinib citrate Tofacitinib, also known as tasocitinib, CP-690550, is a Janus kinase (JAK) inhibitor. Tofacitinib modulates the signaling pathway ..
CR1333	934660-93-2	GDC-0973 Cobimetinib Cobimetinib, also known as GDC-0973 and XL-518 , is an orally bioavailable small-molecule inhibitor of mitogen-activated protein k..
CR1332	783355-60-2	PCI-24781 Abexinostat Abexinostat, also known as PCI-24781 or CRA-024781, is novel, broad-spectrum hydroxamic acid-based inhibitor of histone deacetylas..
CR1331	1300031-49-5	I-BET151 GSK1210151A GSK1210151A, also known as I-BET151, is a BET bromodomain inhibitor, which blocks recruitment of BET to chromatin. I-BET151 ( GSK1..
CR1330	184025-19-2	Ciproxifan maleate Ciproxifan maleate (FUB 359 maleate) is a potent, selective, orally bioavailable and competitive antagonist of histamine H3-recept..
CR1329	1028486-01-2	MLN8237 Alisertib Alisertib, also known as MLN8237, is a second-generation, orally bioavailable, highly selective small molecule inhibitor of the se..
CR1328	53910-25-1	Pentostatin Pentostatin is classified as a purine analog, which is a type of antimetabolite. It mimics the nucleoside adenosine and thus inhib..
CR1327	697761-98-1	GS-9137 Elvitegravir Elvitegravir (EVG, formerly GS-9137) is an integrase inhibitor used to treat HIV infection. The drug gained approval by the U.S. F..
CR1326	945771-96-0	BNC105P BNC105P is a benzofuran-based vascular disrupting agent (VDA) prodrug with potential anti-vascular and antineoplastic activities. ..

首页上一页当前第259/297页共2966条记录每页10条257 258259260 261 下一页尾页

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Friendly link

Address:Economic Developed Zone of Taizhou Zhejiang China